Life Science

13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED₅₀ of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the

13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED₅₀ of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the

13,14-dehydro-15-cyclohexyl Carbaprostacyclin is a chemically stable analog of PGI2. It inhibits the ADP-induced aggregation of human platelets with an ED₅₀ of about 40 nM in PRP and 77 nM in washed platelets, which is comparable to the

Contains a 50 &microg vial of 13,14-dihydro PGE1-d4 and a precisely weighed vial of unlabeled 13,14-dihydro PGE1 (precise weight indicated on the vial) for the convenient, precise quantification of 13,14-dihydro PGE1 by GC- or LC-MS.

13,14-dihydro PGE1 is a biologically active metabolite of PGE1 with comparable potency to the parent compound. It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.

13,14-dihydro PGE1 is a biologically active metabolite of PGE1 with comparable potency to the parent compound. It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.

13,14-dihydro PGE1 is a biologically active metabolite of PGE1 with comparable potency to the parent compound. It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.

13,14-dihydro PGE1 is a biologically active metabolite of PGE1 with comparable potency to the parent compound. It is an inhibitor of ADP-induced platelet aggregation in human PRP and washed platelets with IC50 values of 31 and 21 nM, respectively.

13,14-dh PGE1-d4 contains four deuterium atoms at the 3, 3&#39, 4, and 4&#39 positions. It is intended for use as an internal standard for the quantification of 13,14-dh PGE1 by GC- or LC-mass spectrometry.

13,14-dh PGE1-d4 contains four deuterium atoms at the 3, 3&#39, 4, and 4&#39 positions. It is intended for use as an internal standard for the quantification of 13,14-dh PGE1 by GC- or LC-mass spectrometry.

13,14-dihydro PGF1&alpha is a potential metabolite of PGF1&alpha. Its biological activity has not been reported. The corresponding compound in the E1 series (13,14-dihydro PGE1) retains biological activity similar to PGE1.

13,14-dihydro PGF1&alpha is a potential metabolite of PGF1&alpha. Its biological activity has not been reported. The corresponding compound in the E1 series (13,14-dihydro PGE1) retains biological activity similar to PGE1.